QC
MXCT icon

Quadrature Capital’s MaxCyte MXCT Stock Holding History

Quadrature Capital’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-36,348
Closed -$56.3K – 1689
2025
Q4 		$56.3K Sell
36,348
-7,769
-18% -$12.4K ﹤0.01% 1165
2025
Q3 		$70.1K Buy
44,117
+16,357
+59% +$28.4K ﹤0.01% 928
2025
Q2 		$60.4K Buy
+27,760
New +$67.2K ﹤0.01% 932
2025
Q1 		– Sell
-10,249
Closed -$42.8K – 1340
2024
Q4 		$42.8K Buy
+10,249
New +$38.7K ﹤0.01% 965

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $641M AUM 61.79% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $88.9M AUM

Quadrature Capital's MXCT Position: Q1 2026 in Review

Quadrature Capital sold out of MaxCyte (MXCT) in Q1 2026, closing a stake of 36,348 shares — an estimated $56.3K sold.

Quadrature Capital first reported a position in MXCT in Q4 2024 and held it in 4 quarters. The position peaked at $70.1K in Q3 2025. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Quadrature Capital reported no remaining MaxCyte position as of Q1 2026 after selling out during the quarter.
  • Quadrature Capital sold 36,348 MaxCyte shares in Q1 2026, an estimated $56.3K.
  • Quadrature Capital first reported a position in MaxCyte in Q4 2024 and held it in 4 quarters.
  • Quadrature Capital's MaxCyte position peaked at $70.1K in Q3 2025.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.